Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols.

about

Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols.

Item

http://www.wikidata.org/entity/Q38761720

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacodynamics of Oxaliplati ...... Design of Treatment Protocols.

@en

type

Item

label

Pharmacodynamics of Oxaliplati ...... Design of Treatment Protocols.

@en

prefLabel

Pharmacodynamics of Oxaliplati ...... Design of Treatment Protocols.

@en

P1476

Pharmacodynamics of Oxaliplati ...... Design of Treatment Protocols.

@en

P2093

Alexander Tolios

http://www.w3.org/2001/XMLSchema#string

Alfred Königsrainer

http://www.w3.org/2001/XMLSchema#string

Anne Zeck

http://www.w3.org/2001/XMLSchema#string

Hans-Georg Rammensee

http://www.w3.org/2001/XMLSchema#string

Heiko Schuster

http://www.w3.org/2001/XMLSchema#string

Ingmar Königsrainer

http://www.w3.org/2001/XMLSchema#string

Jürgen Weinreich

http://www.w3.org/2001/XMLSchema#string

Nicolas Quilitz

http://www.w3.org/2001/XMLSchema#string

Philipp Horvath

http://www.w3.org/2001/XMLSchema#string

Stefan Beckert

http://www.w3.org/2001/XMLSchema#string

P2860

Looking up: Recent advances in understanding and treating peritoneal carcinomatosis

High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study.

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis

Pharmacokinetics of oxaliplatin in humans.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Oxaliplatin: a review in the era of molecularly targeted therapy

Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent.

Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer.

Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.

P2888

s10434-017-5790-x

P304

1650-1657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-5790-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sebastian P Haen

Markus W. Löffler

P577

2017-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083535022

http://www.w3.org/2001/XMLSchema#string

P698

28160138

http://www.w3.org/2001/XMLSchema#string